Stocks

Sober Up, Buttercup: Why Quantum BioPharma’s Alcohol Detox Drink ‘unbuzzd’ is a Game-Changer

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) is redefining how we recover from alcohol consumption with its revolutionary product,…

Read More »

Insurance Nightmare: Why Thousands Had Policies Canceled Before LA Wildfires

When the Los Angeles wildfires erupted, reducing thousands of homes to ash and leaving countless families displaced, a secondary crisis…

Read More »

Why Currenc Group (CURR) Stock Skyrocketed 400% Today

Currenc Group (NASDAQ: CURR) stock experienced an incredible surge on Wednesday, climbing over 400% following the announcement of its cutting-edge…

Read More »

Quantum BioPharma Approved to Dual List on Upstream Global Trading App

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced it was approved to dual list its shares on the Upstream…

Read More »

Fubo Stock Triples on Disney Streaming Merger, Why YouTube Should Be Concerned

Fubo (NYSE: FUBO) stock skyrocketed over 250% on Monday after the sports streaming platform announced a groundbreaking deal to merge…

Read More »

Shark Tank’s Kevin O’Leary Wants to Buy TikTok, Here’s How You Can Invest Too

Kevin O’Leary, the “Shark Tank” investor affectionately known as “Mr. Wonderful,” has set his sights on TikTok. Amid growing national…

Read More »

Quantum BioPharma Buys $1 Million of Bitcoin and Other Crypto

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) announced that the company has purchased USD $1 million worth of Bitcoin…

Read More »

How This $4 Stock is Taking on Wall Street’s Big Banks with a $700 Million Lawsuit

Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91), a small biopharmaceutical company with an $8 million market cap, has launched…

Read More »

Fed Cuts Rates, Stocks and Crypto Slide on Powell’s Hawkish Tone

On Wednesday, the Federal Reserve’s decision to cut interest rates by 25 basis points sent shockwaves through financial markets, with…

Read More »

4 Stocks Leading the Charge in the $20 Billion Race to Stop the Progression of Multiple Sclerosis

The multiple sclerosis (MS) treatment market, valued at over $20 billion annually, is experiencing a transformative phase. With no definitive…

Read More »
Back to top button
🔔
Stay Updated!
Get notifications for new content